2.37
price down icon2.47%   -0.06
after-market Dopo l'orario di chiusura: 2.37
loading

Cognition Therapeutics Inc Borsa (CGTX) Ultime notizie

pulisher
08:40 AM

Does Cognition Therapeutics Inc. have pricing power2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - khodrobank.com

08:40 AM
pulisher
08:03 AM

Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone - Investing.com

08:03 AM
pulisher
08:01 AM

Trend analysis for Cognition Therapeutics Inc. this weekPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser

08:01 AM
pulisher
07:42 AM

Cognition Therapeutics, Inc. Achieves 75% Enrollment in Phase 2 START Study for Early Alzheimer’s Disease Treatment - Quiver Quantitative

07:42 AM
pulisher
07:33 AM

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target - GlobeNewswire

07:33 AM
pulisher
07:30 AM

540-Patient Alzheimer's Trial: Cognition's Once-Daily Oral Drug Zervimesine Reaches Major Milestone - Stock Titan

07:30 AM
pulisher
07:23 AM

Visualizing Cognition Therapeutics Inc. stock with heatmaps2025 AllTime Highs & Daily Profit Focused Screening - Newser

07:23 AM
pulisher
06:03 AM

What’s next for Cognition Therapeutics Inc. stock price2025 Performance Recap & Growth-Oriented Investment Plans - Newser

06:03 AM
pulisher
05:40 AM

What moving averages say about Cognition Therapeutics Inc.Weekly Trade Report & AI Enhanced Trade Execution Alerts - Newser

05:40 AM
pulisher
05:12 AM

Top chart patterns to watch in Cognition Therapeutics Inc.2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser

05:12 AM
pulisher
05:01 AM

MACD Cross Could Confirm Trend in Cognition Therapeutics Inc.Weekly Market Summary & AI Enhanced Trading Alerts - beatles.ru

05:01 AM
pulisher
04:37 AM

Cognition Therapeutics shares fall 1.23% premarket after closing a $30 million registered direct offering. - AInvest

04:37 AM
pulisher
04:34 AM

How to integrate Cognition Therapeutics Inc. into portfolio analysis toolsJuly 2025 Decliners & Advanced Technical Analysis Signals - Newser

04:34 AM
pulisher
04:25 AM

Is Cognition Therapeutics Inc. still worth holding after the dipGold Moves & Free Safe Capital Growth Stock Tips - Newser

04:25 AM
pulisher
04:08 AM

Real time scanner hits for Cognition Therapeutics Inc. explained2025 Valuation Update & Daily Chart Pattern Signal Reports - Newser

04:08 AM
pulisher
03:45 AM

Published on: 2025-09-03 02:45:26 - Newser

03:45 AM
pulisher
03:45 AM

Will Cognition Therapeutics Inc. stock go up soonJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser

03:45 AM
pulisher
03:00 AM

How to build a custom watchlist for Cognition Therapeutics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser

03:00 AM
pulisher
02:49 AM

What to expect from Cognition Therapeutics Inc. in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser

02:49 AM
pulisher
01:50 AM

Cognition Therapeutics Inc. stock retracement – recovery analysis2025 Technical Overview & Stock Timing and Entry Methods - Newser

01:50 AM
pulisher
12:32 PM

Real time pattern detection on Cognition Therapeutics Inc. stockWeekly Profit Report & Consistent Return Strategy Ideas - Newser

12:32 PM
pulisher
Sep 02, 2025

Automated trading signals detected on Cognition Therapeutics Inc.Take Profit & Expert Curated Trade Setup Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Cognition Therapeutics Inc. stock trend forecastJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cognition Therapeutics Inc. trading at a discountJuly 2025 Trends & Smart Money Movement Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Cognition Therapeutics Closes $30 Million Direct Offering - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

Cognition Therapeutics closes $30 million registered direct offering - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812) - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

$30 Million Funding: Cognition Therapeutics Advances Breakthrough Neurodegenerative Drug to Phase 3 - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Chart overlay techniques for tracking Cognition Therapeutics Inc.Trade Volume Summary & Consistent Profit Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tick level data insight on Cognition Therapeutics Inc. volatilityBuy Signal & Weekly Breakout Watchlists - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Cognition Therapeutics Inc. stock prediction for this weekJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Should you avoid Cognition Therapeutics Inc. stock right now2025 Trading Volume Trends & Real-Time Sentiment Analysis - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

How moving averages guide Cognition Therapeutics Inc. tradingJuly 2025 Spike Watch & Safe Entry Point Identification - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Cognition Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Setups & Safe Capital Allocation Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Leading vs lagging indicators on Cognition Therapeutics Inc. performanceJuly 2025 Opening Moves & Reliable Trade Execution Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Intraday pattern recognizer results for Cognition Therapeutics Inc.Market Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Multi asset correlation models including Cognition Therapeutics Inc.July 2025 Earnings & Daily Stock Trend Reports - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Ranking Cognition Therapeutics Inc. among high performing stocks via toolsPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Identifying reversal signals in Cognition Therapeutics Inc.Quarterly Portfolio Report & Verified Momentum Stock Watchlist - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How sentiment analysis helps forecast Cognition Therapeutics Inc.2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What technical models suggest about Cognition Therapeutics Inc.’s comeback2025 EndofYear Setup & Community Consensus Stock Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Cognition Therapeutics Inc. Forming a Bottom Pattern getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
Capitalizzazione:     |  Volume (24 ore):